Proteins such as prolylcarboxypeptidase, LEP, EDIL3 and apolipoprotein A-IV (APOA4) showed the same trend of expression between patients with T2D and controls in the two populations (Fig. 2c). The gene discussed is APOA4; the disease is type 2 diabetes mellitus.